A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Clinical trial NCT05088642 · COMPLETED

Trial details

NCT number: NCT05088642
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sever Aplastic Anaemia

Start date: 2020-09-28
Primary completion: 2020-12-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.